Skip to product information
1 of 2

Dr.Hepo

easypharm Erazaban cold sore cream 2 gr

easypharm Erazaban cold sore cream 2 gr

Regular price $45.50 USD
Regular price Sale price $45.50 USD
Sale Sold out
Taxes included.

Docosanol is an antiviral agent. Erazaban is a white cream used to treat early-stage recurrent cold sores (cold sores) in adults and adolescents (over 12 years of age).

To be effective, treatment with Erazaban must be started at the beginning of a cold sore, before blisters appear. Start using Erazaban as soon as you experience any of the symptoms of a cold sore such as redness, itching, pain, tingling or stinging. Continue use until the cold sore is gone, usually 4 to 6 days.

Fever blisters are caused by infection with the herpes simplex virus. The infection can break out when the immune system is weakened, under stress or during menstruation. The virus causes blisters or sores, mainly on the lips.

Contraindications

Do not use Erazaban 100 mg/g Cream if you are hypersensitive (allergic) to docosanol or any of the other ingredients of Erazaban 100 mg/g Cream listed at the end of this leaflet (see section 6). 

interactions

Erazaban must not be used with other topical products (drugs, cosmetic products, creams) at the same administration site.
It is unlikely that Erazaban will affect or be affected by other medicines as Erazaban is intended for cutaneous use only. However, do not use other cold sore medicines while using Erazaban.

Ask your pharmacist if you have any further questions about how Erazaban is affected by other medicines or how it affects other medicines.

Please inform your doctor or pharmacist if you are taking/using or have recently taken/used other medicines, even if they are non-prescription medicines.

Pregnancy and breast-feeding
Erazaban can be used during pregnancy and breast-feeding.

Important information about some of the ingredients of Erazaban 100 mg/g cream
Erazaban contains propylene glycol which may cause skin irritation. 

application

  • Adults and adolescents over 12 years: Start treatment as soon as you notice the first symptoms or signs of a cold sore, for example: itching, stinging, burning or tingling in the affected area.
  • Wash your hands thoroughly before and after treatment to avoid spreading the infection.
  • Carefully apply a thin film to the entire cold sore 5 times a day. (Approximately every 3 hours while awake)
  • Use a fingertip or preferably a cotton swab and avoid touching the tube opening after touching the cold sore.
  • Continue treatment until complete healing, usually between 4 and 6 days.
  • If you do not notice any improvement after 10 days, you must stop treatment and consult your doctor.
  • Remember that Erazaban is your medicine. If you lend the tube to someone else, you risk spreading the infection to others. 

side effects

Like all medicines, Erazaban can cause side effects, although not everyone gets them. 

The following expressions are used for the frequency of occurrence of side effects: very common (more than 1 in 10 people treated), common (between 1 in 100 people treated and 1 in 10 people treated), uncommon (between 1 in 1,000 people treated and 1 in 100 people). treated), rare (between 1 in 10,000 and 1 in 1,000 people treated), very rare (less than 1 in 10,000 people treated). 

Nervous system problems:
Very common: Headache 

Skin problems:
Common: Skin disorders including dry skin, rashes and facial swelling where the cream was applied 

If a more serious skin reaction occurs, you must stop treatment and, if the problem does not go away, you should contact your doctor. 

Please tell your doctor or pharmacist if any of the side effects gets serious, or if you notice any side effects not listed in this leaflet.

composition

The active substance is docosanol.

1 g cream contains 100 mg docosanol. 

                                                                                          Your order will be shipped within 3-4 business days
                                                                                          View full details